Floydf Petersen News Today

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) Director Floyd F. Petersen sold 3,000 shares of Amphastar Pharmaceuticals stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $41.40, for a total value of $124,200.00. Following the completion of the sale, the director now directly owns 78,409 shares […]

Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of $0.73 per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link. […]

China Universal Asset Management Co. Ltd. increased its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 339.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,542 shares of the company’s stock after buying an additional 4,281 […]

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) Director Floyd F. Petersen sold 500 shares of the stock in a transaction on Monday, April 1st. The stock was sold at an average price of $43.43, for a total value of $21,715.00. Following the completion of the sale, the director now directly owns 79,333 shares in […]

Eagle Asset Management Inc. trimmed its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 45.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 37,701 shares of the company’s stock after selling 31,888 shares during the quarter. Eagle […]

Nordea Investment Management AB trimmed its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.1% during the third quarter, Holdings Channel.com reports. The fund owned 338,443 shares of the company’s stock after selling 349 shares during the quarter. Nordea Investment Management AB’s holdings in Amphastar Pharmaceuticals were worth $15,700,000 as of […]

StockNews.com cut shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a buy rating to a hold rating in a research note released on Tuesday. Separately, Bank of America began coverage on shares of Amphastar Pharmaceuticals in a research note on Friday, November 17th. They set a neutral rating and a $63.00 price objective on […]

StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a hold rating to a buy rating in a research note released on Friday morning. Separately, Bank of America started coverage on Amphastar Pharmaceuticals in a research note on Friday, November 17th. They issued a neutral rating and a $63.00 price objective on the […]

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) Director Floyd F. Petersen sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $61.37, for a total transaction of $30,685.00. Following the sale, the director now owns 80,833 shares in the […]

Shariaportfolio Inc. acquired a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 12,505 shares of the company’s stock, valued at approximately $575,000. Other institutional investors and hedge funds […]